Molecular mechanisms of dominant negative activity by nuclear hormone receptors

Molecular Endocrinology

Volumn 8, Issue 11, 1994, Pages 1450-1454

  Yen, Paul M ^a   Chin, William W ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; NUCLEAR FACTOR; PROGESTERONE RECEPTOR; RETINOIC ACID BINDING PROTEIN; THYROID HORMONE RECEPTOR; VITAMIN RECEPTOR;

AUTOSOMAL DOMINANT INHERITANCE; BINDING COMPETITION; DIMERIZATION; DNA BINDING; ELECTROPHORETIC MOBILITY; HORMONE RESISTANCE; HORMONE RESPONSIVE ELEMENT; LIGAND BINDING; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; TRANSCRIPTION INITIATION;

CELL NUCLEUS; DNA; DNA-BINDING PROTEINS; HUMAN; MUTATION; ONCOGENE PROTEINS V-ERBA; PROTEIN CONFORMATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, THYROID HORMONE; REGULATORY SEQUENCES, NUCLEIC ACID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYROID HORMONE RESISTANCE SYNDROME; TRANS-ACTIVATION (GENETICS);

EID: 0028037369     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/mend.8.11.7877614     Document Type: Article

References (37)

1. Heskowitz I 1987 Functional inactivation of genes by dominant negative mutations. Nature 329:219-222
2. Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A, Evans RM 1994 A novel maoromolecular structure is a target of the promyelocytic-retinotc receptor oncoprotein. Cell 75:333-343
3. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A 1994 Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytie leukemia cells. Cell 75:345-356
4. Huang ME, Yu-Chen Y, Shu-Rong C, Jin-Ren C, Jia-Xiang L, Long-Jun G, Zhen-Yi W 1988 Use of all trans retinoic acid in the treatment of acute promyelocytie leukemia. Blood 72:567-572
5. Chen Z, Brand NJ, Chen A, Chen S-J, Tong J-H, Wang Z-Y, Waxman S, Zelent A 1993 Fusion between a novel KruppeWike zinc finger gene and the retinoic acid-a locus due to a variant t(11:17) translocation associated with acute promyelocytie leukaemia. EMBO J 12:1161-1167
6. De The H, Marchio A, Tiollais P, Dejean A 1987 A novel steroid thyroid hormone receptor-rclatod gene inappropriately expressed in hepatocellular carcinoma. Nature 330:667-670
7. McGuire WL, Chamners GC, Tuqua SAW 1991 Cstrogen receptor variants in clinical breast cancer. Mol Endocrinol 5:1571-1577
8. MCPham MJ, Marcelli M, zoppi S, Wilson CM, Griffin JE, Wilson JD 1993 Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. J Clin Invest 90:2097-2101
9. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, O'Malley BW 1988 Point mutations in the human vitamin D receptor gene associated with hypocalcémie rickets Science 242:1702-1705
10. 3. J Clin Invest 92:12-16
11. Chrousos GP, Detera-Wadleigh SD, Karl M 1993 Syndromes of glucocorticoid resistance. Ann Intern Med 119:1113-1124
12. Takeda K, Sakurai A, Degroot U, Refetoff S 1992 Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor β gene. J Clin Endocrinol Metab 74:49-55
13. Refetoff S, Weiss RA, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
14. Sakurai A, Miyamoto T, Refetoff S, Degroot LJ 1990 Dominant negative transcriptional regulation by a mutant thyroid hormone receptor β in a family with generalized resistance to thyroid hormone. Mol Endocnnol 4:1988-1994
15. Meier C, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ranson SC, Menke JB, Hao EH, Usala SJ, Bereu BB, Cheng SY, Weintraub BD 1992 Variable transcriptional activity and ligand binding of mutant β1-3.5.3' triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6:248-258
16. Forman BM, Samuels HH 1990 interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. Mol Endocrinol 4:1293-1301
17. Vegeto E, Shahbez MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP 1993 Human progesterone receptor A form is a cell-and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7:1244-1255
18. Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB 1993 Antagonist-occupied human progesterone B receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A receptors. Mol Endocrinol 7:1256-1265
19. Damm K, Thompson CC, Evans RM 1989 Protein encoded by v-erbA functions as a thyroid hormone antagonist. Nature 339:593-597
20. Sap J, Munoz A, Schmitt J, Stunnenberg H, Vennstrom B 1989 Repression of transcription mediated at a thyroid hormone response element by v-erb-A oncogene product Nature 340:242-244
21. Disela C, Glineur C, Bugge T, Sap J, Stengl G, Dodgson J, Stunnenberg H, Beug H, Zenke M 1991 v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAM, Genes Dev 5:2033-2047
22. Yen PM, Ikeda M, Brubaker JH, Forgione M, Sugawara A, Chin WW 1994 Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA. J Biol Chem 269:903-909
23. Yen PM, Sugawara A, Refetoff S, Chin WW 1992 New insights on the mechamsm(s) of the dominant negative effect of mutant thyroid hormone receptors in generalized resistance to thyroid hormone. J Clin Invest 90:1825-1831
24. Nagaya T, Madison UD, Jameson JL 1992 Thyroid hormone receptor mutants that cause resistance to thyroid hormone: evidence for receptor competition for DNA sequences in target genes. J Biol Chem 267:13014-13019
25. Koenig RJ, Lazar MA, Hodm RA, Brent GA, Larsen PR, Chin WW, Moore DD 1989 Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 337:659-661
26. Katz D, Lazar MA 1993 Dominant negative activity of an endogenous thyroid hormone receptor variant (α-2) is due to competition for binding sites on target genes. J Biol Chem 268 20904-20910
27. 1 a potential endogenous antagonist of glucocorticoid action. Program of the 76th Annual Meeting of The Endocrine Society. Anaheim CA, 1994 (Abstract 264)
28. Graupner G, Willis KN, Tzukerman M, Zhang X-K, Pfahl M 1989 Dual regulatory role for thyroid-hormone receptors allows control of retinoic retinoic acid receptor activity. Nature 340:653-656
29. Segars JH, Marks MS, Hirschfeld S, Driggers PH, Martinez E, Grippo JF, Wahli W, Ozato K 1993 Inhibition of estrogen-responsive gene activation by the retinoic X receptor β: evidence for multiple inhibitory pathways. Mol Cell Biol 13:2258-2268
30. Meyer M-E, Gronemeyer H, Turcotte B, Boquel M-T, Tasset D, Chambón P 1989 Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433-442
31. Fondell JD, Roy AL, Roeder RG 1993 Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes Dev 7:1400-1410
32. Baniahmad A, Ha I, Reinberg D, Tsai S, Tsai M-J, O'Malley BW 1993 Interaction of human thyroid hormone receptor β with transcription factor TFHB may mediate target gene derepression and activation by thyroid hormone. Proc Natl Acad Sci USA 90:8832-8836
33. Goldman ME, McOonnell DP 1994 RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J Biol Chem 269:11945-11949
34. 3R, but not its oncogenic variant. v-erbA. suppresses RAR-dependent transactivation by titrating out RXR, EMBO J 12:1343-1354
35. Behr M, Loos U 1992 A point mutation (Ala229 to Thr) in the hinge domain of the c-erbAβ thyroid hormone receptor gene in a family with generalized thyroid hormone resistance Mol Endocrinol 6:1119-1126
36. Ince BA, Zhuang Y, Wrenn CK, Shapiro DJ, Katzenellenbogen BS 1993 Powerful dominant negative mutants of the human estrogen receptor. J Biol Chem 268:14026-14032
37. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW 1991 Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254:1636-1639